ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,222.68
0.16%
Dow Jones
39,512.84
0.32%
US Dollar vs MXN
16.7804
0.00%
Brent Oil
82.585
0.00%
Bitcoin
61,298.27
0.82%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Avalon Pharmaceuticals (MM) (AVRX)

  7. Avalon Pharmaceuticals (MM) (AVRX) Noticias

AVRX

Avalon (AVRX)

Avalon Pharmaceuticals (MM)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:AVRX
FechaHoraFuenteTítuloSímboloCompañía
13/05/200914:39Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
06/05/200915:48Edgar (US Regulatory)Current report filing (8-K)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
06/05/200915:46Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
28/04/200915:49Business WireAvalon Pharmaceuticals Announces Special Meeting DateNASDAQ:AVRXAvalon Pharmaceuticals (MM)
07/04/200914:00Business WireAvalon Pharmaceuticals Receives Audit Opinion Containing Going Concern StatementNASDAQ:AVRXAvalon Pharmaceuticals (MM)
17/03/200914:00Business WireAvalon Pharmaceuticals Receives Staff Determination Regarding Nasdaq DelistingNASDAQ:AVRXAvalon Pharmaceuticals (MM)
10/03/200915:07Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
11/02/200915:11Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
10/02/200916:04Edgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
22/12/200815:23Business WireAvalon Pharmaceuticals Receives Extension of Time to Comply with NASDAQ Deficiency NoticeNASDAQ:AVRXAvalon Pharmaceuticals (MM)
25/11/200813:18Business WireAvalon Pharmaceuticals Receives NASDAQ Deficiency NoticeNASDAQ:AVRXAvalon Pharmaceuticals (MM)
07/11/200815:04Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (D)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
05/11/200815:29Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
28/10/200807:26Business WireClinical Data, Inc. to Acquire Avalon PharmaceuticalsNASDAQ:AVRXAvalon Pharmaceuticals (MM)
29/09/200814:16Edgar (US Regulatory)Avalon Pharmaceuticals Inc - Current report filing (8-K)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
26/09/200815:16Business WireAvalon Pharmaceuticals Receives Nasdaq Deficiency NoticeNASDAQ:AVRXAvalon Pharmaceuticals (MM)
26/08/200810:02Edgar (US Regulatory)Avalon Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
14/08/200810:53Edgar (US Regulatory)Avalon Pharmaceuticals Inc - Quarterly Report (10-Q)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
13/08/200809:00Business WireAvalon Pharmaceuticals Reports Second Quarter 2008 ResultsNASDAQ:AVRXAvalon Pharmaceuticals (MM)
05/08/200808:00Business WireAvalon Pharmaceuticals Sets Second Quarter 2008 Conference Call DateNASDAQ:AVRXAvalon Pharmaceuticals (MM)
24/07/200811:07Edgar (US Regulatory)Avalon Pharmaceuticals Inc - Amended Current report filing (8-K/A)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
18/07/200813:23Edgar (US Regulatory)Avalon Pharmaceuticals Inc - Confidential Treatment Order (CT ORDER)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
26/06/200807:00Business WireAvalon Pharmaceuticals Nominates Lead Clinical Development Candidate in its Beta-catenin Pathway Inhibitor ProgramNASDAQ:AVRXAvalon Pharmaceuticals (MM)
07/05/200815:20Business WireAvalon Pharmaceuticals Reports First Quarter 2008 ResultsNASDAQ:AVRXAvalon Pharmaceuticals (MM)
30/04/200807:00Business WireAvalon Pharmaceuticals to Release First Quarter 2008 ResultsNASDAQ:AVRXAvalon Pharmaceuticals (MM)
29/04/200808:54Edgar (US Regulatory)Avalon Pharmaceuticals Inc - Proxy Statement (definitive) (DEF 14A)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
14/04/200810:00Business WireAvalon Pharmaceuticals Identifies Small Molecule Inhibitors of the Aurora/Centrosome Cancer Pathway that Block PLK3 Protein FuncNASDAQ:AVRXAvalon Pharmaceuticals (MM)
31/03/200813:34Edgar (US Regulatory)Avalon Pharmaceuticals Inc - Annual Report (10-K)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
19/03/200815:15Business WireAvalon Pharmaceuticals Reports Fourth Quarter and Full Year 2007 ResultsNASDAQ:AVRXAvalon Pharmaceuticals (MM)
17/03/200814:57Edgar (US Regulatory)Avalon Pharmaceuticals Inc - Initial Statement of Beneficial Ownership (3)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
 Showing the most relevant articles for your search:NASDAQ:AVRX

Su Consulta Reciente

USOTC
DTEGY
Deutsche Telekom (QX)
CCOM
US30
US 30
NYSE
KO
Coca Cola
NYSE
DIS
Walt Disney
USI
USTECH100
US Tech 100
CCOM
SILVER
SILVER
FX
USDMXN
US Dollar vs MXN
NYSE
MCD
McDonalds
NYSE
CVX
Chevron
COIN
BTCUSD
Bitcoin
COIN
SOLUSD
Solana
NYSE
JPM
JP Morgan Chase
COIN
ETHUSD
Ethereum
NASDAQ
QQQ
Invesco QQQ Trust Series 1
USOTC
RHHBY
Roche (QX)
NYSE
AXP
American Express
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados